Kingsley Chin, MD, is stepping down as CEO of NanoFuse Biologics following the company's merger into a newly formed medtech company.
The Latest
This year, 7,300 doctors of osteopathic medicine have entered the workforce, making DOs 25 percent of the medical school student population, according to a Sept. 8 report from Medscape.
The Atlantic General Hospital Orthopedic Surgery unit in Berlin, Md., is set to receive a Stryker Mako robotic arm in mid September, according to a Sept. 8 report from OC Today.
From FDA approvals to studies, here are six key updates in total disc replacements since July 1.
Becker's has reported on four studies since Aug. 23 that spine and orthopedic surgeons should know.
Utah-based developer Novarad Corp. has announced a strategic alliance with several neurosurgical and spine distributors across the U.S. to distribute its AR surgical navigation system, VisAR.
The American Academy of Orthopaedic Surgeons has issued an update to the clinical practice guideline for management of anterior cruciate ligament injuries, replacing the previous version released in 2014.
Private equity investments have grown in the spine and orthopedic space, with many physicians taking advantage of the opportunities it offers. However, there are also concerns among experts about the long-term viability of taking outside capital.
Johnson & Johnson is planning to develop its own spine robot to rival the platforms launched by Medtronic, Globus Medical and emerging device companies, company executives said Sept. 7 during the 2022 Wells Fargo Healthcare Conference, according to Seeking Alpha.
It's not uncommon for some orthopedic surgeries to be done in the outpatient setting, but many factors go into creating a successful program.